Kalaris Therapeutics Inc (KLRS)

$6.64 -0.45 (-6.35%)
Market Cap 124.18M
Revenue (ttm) 0.00
Net Income (ttm) -58.77M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 113,200
Avg Vol 355,458
Day's Range N/A - N/A
Shares Out 18.70M
Stochastic %K 70%
Beta 0.42
Analysts Strong Sell
Price Target $16.75

Company Profile

Kalaris Therapeutics, Inc., a clinical-stage ophthalmology biotech company, engages in developing therapies for the treatment of neovascular retinal diseases. Kalaris Therapeutics, Inc. was formerly known as Theia Therapeutics, Inc. and changed its name to Kalaris Therapeutics, Inc. in May 2024. The company was incorporated in 2019 and is based in Palo Alto, California.

Industry: Biotechnology
Sector: Healthcare
Address:
628 Middlefield Road, Palo Alto, United States
pumpdrew
pumpdrew Oct. 5 at 9:14 AM
$KLRS Technology services speculation. No fundamental support. Chart shows pump-and-dump characteristics. Avoid.
0 · Reply
Vikingsstrade
Vikingsstrade Oct. 3 at 4:22 PM
$KLRS $XELB $MRAM $GPUS Merger news on NITO and it barely has 3 million market cap. If people find this, short sellers could get hurt alot on NITO. Small caps have been dead for a while, but NITO gives me hope that short sellers finally get what they deserve!
0 · Reply
SuperNovaBank
SuperNovaBank Oct. 3 at 5:26 AM
Top watch: GIPR The intrinsic value for GIPR is pegged at $13.53+ per share 🚀 — compare that to current levels 👀 and you’ll see just how MASSIVELY undervalued this play is. With the strategic alternatives process in motion (Cantor Fitzgerald onboard, potential merger, sale, or recap), the upside potential here is unreal. This isn’t just speculation — the numbers are CLEAR 📊. GIPR is trading at a deep discount to its real worth. Smart money will catch on fast. Don’t sleep on this one. 🚨📈... $KLRS $ASTS $CRCL $VEEA
0 · Reply
JoshThe3rd
JoshThe3rd Oct. 3 at 4:48 AM
$KLRS this shouldn't be trading over cash with no P1 data. As you saw with KALA doesn't take much volume to pump this up before data. Remember as a warning Samsara was so bullish on TH103 they used Allovir's cash instead of theirs.
2 · Reply
topstockalerts
topstockalerts Oct. 2 at 2:48 PM
$KLRS setting up nicely..
0 · Reply
TV010
TV010 Oct. 2 at 2:35 PM
$KLRS nice moves
0 · Reply
56kw
56kw Sep. 28 at 5:51 PM
$KLRS It keeps moving up, I'll keep buying.
0 · Reply
DrNyseNasdaq
DrNyseNasdaq Sep. 26 at 7:02 PM
Could anyone explain to me ? I made a post here saying that I recommended buying $SOGP in June @ 1.25 $ on my LinkedIn account in June and it surged in 3 months to 38 $ and Recommended buying $ATCH @ 0.195 and it surged to 2.40 $ also in 3 months. And here I'm recommending buying $KLRS @ 4.47 $ (while posting) . Someone asked me to provide the LinkedIn post for SOGP and I did. Now, when I checked the post I got surprised by deleting the post and just keeping the comment . Why ??????????????? What's the violation or the wrong I did to delete my post ???????????
0 · Reply
topstockalerts
topstockalerts Sep. 26 at 6:38 PM
$KLRS setting up nicely.. 💰
0 · Reply
Bswartz95
Bswartz95 Sep. 26 at 4:45 PM
$KLRS is this going to squeeze?
0 · Reply
Latest News on KLRS
UPDATE – Kalaris Therapeutics Now Enrolling Phase 1b/2 Multiple Ascending Dose Study of TH103 in Neovascular Age-Related Macular Degeneration

Sep 15, 2025, 3:26 PM EDT - 19 days ago

UPDATE – Kalaris Therapeutics Now Enrolling Phase 1b/2 Multiple Ascending Dose Study of TH103 in Neovascular Age-Related Macular Degeneration

Kalaris Therapeutics Now Enrolling Phase 1b/2 Multiple Ascending Dose Study of TH103 in Neovascular Age-Related Macular Degeneration

Sep 15, 2025, 8:00 AM EDT - 19 days ago

Kalaris Therapeutics Now Enrolling Phase 1b/2 Multiple Ascending Dose Study of TH103 in Neovascular Age-Related Macular Degeneration

Kalaris Reports Second Quarter 2025 Financial Results and Provides Business Updates

Aug 13, 2025, 8:00 AM EDT - 7 weeks ago

Kalaris Reports Second Quarter 2025 Financial Results and Provides Business Updates

Kalaris to Present at Noble Capital Markets 2025 Emerging Growth Equity Conference

Jun 2, 2025, 8:00 AM EDT - 4 months ago

Kalaris to Present at Noble Capital Markets 2025 Emerging Growth Equity Conference

Kalaris to Participate at Stifel Ophthalmology Forum

May 23, 2025, 11:03 AM EDT - 4 months ago

Kalaris to Participate at Stifel Ophthalmology Forum

Kalaris Reports First Quarter 2025 Financial Results and Provides Business Highlights

May 14, 2025, 8:00 AM EDT - 5 months ago

Kalaris Reports First Quarter 2025 Financial Results and Provides Business Highlights

Kalaris Expands Board of Directors Appointing Leone Patterson as Chair of Audit Committee

Apr 4, 2025, 8:00 AM EDT - 6 months ago

Kalaris Expands Board of Directors Appointing Leone Patterson as Chair of Audit Committee

Kalaris Announces Closing of Merger with AlloVir

Mar 18, 2025, 4:21 PM EDT - 7 months ago

Kalaris Announces Closing of Merger with AlloVir

ALVR

pumpdrew
pumpdrew Oct. 5 at 9:14 AM
$KLRS Technology services speculation. No fundamental support. Chart shows pump-and-dump characteristics. Avoid.
0 · Reply
Vikingsstrade
Vikingsstrade Oct. 3 at 4:22 PM
$KLRS $XELB $MRAM $GPUS Merger news on NITO and it barely has 3 million market cap. If people find this, short sellers could get hurt alot on NITO. Small caps have been dead for a while, but NITO gives me hope that short sellers finally get what they deserve!
0 · Reply
SuperNovaBank
SuperNovaBank Oct. 3 at 5:26 AM
Top watch: GIPR The intrinsic value for GIPR is pegged at $13.53+ per share 🚀 — compare that to current levels 👀 and you’ll see just how MASSIVELY undervalued this play is. With the strategic alternatives process in motion (Cantor Fitzgerald onboard, potential merger, sale, or recap), the upside potential here is unreal. This isn’t just speculation — the numbers are CLEAR 📊. GIPR is trading at a deep discount to its real worth. Smart money will catch on fast. Don’t sleep on this one. 🚨📈... $KLRS $ASTS $CRCL $VEEA
0 · Reply
JoshThe3rd
JoshThe3rd Oct. 3 at 4:48 AM
$KLRS this shouldn't be trading over cash with no P1 data. As you saw with KALA doesn't take much volume to pump this up before data. Remember as a warning Samsara was so bullish on TH103 they used Allovir's cash instead of theirs.
2 · Reply
topstockalerts
topstockalerts Oct. 2 at 2:48 PM
$KLRS setting up nicely..
0 · Reply
TV010
TV010 Oct. 2 at 2:35 PM
$KLRS nice moves
0 · Reply
56kw
56kw Sep. 28 at 5:51 PM
$KLRS It keeps moving up, I'll keep buying.
0 · Reply
DrNyseNasdaq
DrNyseNasdaq Sep. 26 at 7:02 PM
Could anyone explain to me ? I made a post here saying that I recommended buying $SOGP in June @ 1.25 $ on my LinkedIn account in June and it surged in 3 months to 38 $ and Recommended buying $ATCH @ 0.195 and it surged to 2.40 $ also in 3 months. And here I'm recommending buying $KLRS @ 4.47 $ (while posting) . Someone asked me to provide the LinkedIn post for SOGP and I did. Now, when I checked the post I got surprised by deleting the post and just keeping the comment . Why ??????????????? What's the violation or the wrong I did to delete my post ???????????
0 · Reply
topstockalerts
topstockalerts Sep. 26 at 6:38 PM
$KLRS setting up nicely.. 💰
0 · Reply
Bswartz95
Bswartz95 Sep. 26 at 4:45 PM
$KLRS is this going to squeeze?
0 · Reply
Bswartz95
Bswartz95 Sep. 26 at 3:42 PM
$KLRS let’s goooo! $6 is realistic.
1 · Reply
saltylmnt
saltylmnt Sep. 26 at 3:22 PM
$KLRS maybe someone new looking at the r/r on this today?
0 · Reply
BigSqueezeComing
BigSqueezeComing Sep. 23 at 7:57 PM
$KLRS strong buy alerted. Added to watchlist for AH
0 · Reply
topstockalerts
topstockalerts Sep. 23 at 12:11 PM
$KLRS heating up… 🚨
0 · Reply
saltylmnt
saltylmnt Sep. 22 at 9:15 PM
$KLRS is this interesting? designed to be a me too better eylea, trades near cash (~0 EV), tiny float, smart-money holder (owns >60%), co-founded by dr ferrara (avastin), q4 ph1a data in namd, maybe similar to $KOD setup in 2019?
0 · Reply
GMExAPE
GMExAPE Sep. 17 at 9:12 PM
RMFC stock has 5X potential, shorts at zero borrow and the 3m float is locked. Very undervalued here - No dilution - Catalysts coming - Just reported record financials and added a new store a few weeks ago. $KLRS $DMYY $AGH $RICK $PRLD on watch
0 · Reply
Robotai
Robotai Sep. 17 at 12:16 AM
$KLRS Alerted at $4.05
0 · Reply
Love_To_Learn
Love_To_Learn Sep. 16 at 6:47 PM
$KLRS took the cat out the bag
1 · Reply
Love_To_Learn
Love_To_Learn Sep. 16 at 6:46 PM
$KLRS raising u up!
0 · Reply
Orlandotrader
Orlandotrader Sep. 16 at 6:12 PM
$KLRS Well lookey here.
1 · Reply
Bearpicks
Bearpicks Sep. 16 at 3:22 PM
$KLRS Technical breakout 4.50 we clear above 5 on the 4 hour
0 · Reply
Robotai
Robotai Sep. 16 at 3:03 PM
$KLRS 📈 Follow & Subscribe Swing Trading Forecast: $KLRS 📍 Current Price: $4.05 🔍 Swing Patterns: Major Upside Breakout 🔀 Major Signals: Bullish Trend Cross (26/100) 📊 Swing Market Structure: • Trend Regime: Neutral • Direction: Strong Bullish (88.4% confidence) • Timeframe: 3-7 days 🎯 Strong Bullish Swing Targets: • Conservative: $4.63 (+14.18%) • Primary Target: $5.01 (+23.64%) • Aggressive: $5.78 (+42.54%) • Holding Period: 3-7 days 📊 Technical Indicators: • ADX (Trend Strength): 29.5 • ATR (Volatility): $0.07 • RSI: 69.4 • MACD: Bullish 🧠 Historical Pattern Match: • Similar to: 2025-09-16 📈 Swing Signal Strength: 88.4% | Historical Patterns: 2
0 · Reply